Krystal Biotech (KRYS)

Krystal Biotech (KRYS) Financial Statements


Krystal Biotech Financial Overview

Krystal Biotech's market cap is currently ―. The company's EPS TTM is $1.882; its P/E ratio is 88.63; Krystal Biotech is scheduled to report earnings on November 4, 2024, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Sep 23Jun 23Mar 23Dec 22Sep 22
Income Statement-
Total Revenue$ 8.60M---$ 0.00
Gross Profit$ 8.60M----
EBIT$ 74.50M$ -38.05M$ -48.82M-$ -29.85M
EBITDA$ 75.32M$ -38.05M$ -48.12M-$ -28.88M
Net Income Common Stockholders$ 81.24M$ -33.21M$ -45.30M-$ -29.85M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 562.07M$ 477.52M$ 350.39M$ 379.17M$ 394.42M
Total Assets$ 790.35M$ 684.03M$ 531.85M$ 558.45M$ 576.38M
Total Debt$ 8.32M$ 8.54M$ 8.76M$ 8.93M$ 9.12M
Net Debt$ -553.75M$ -468.97M$ -341.63M$ -370.24M$ -385.30M
Total Liabilities$ 34.40M$ 30.91M$ 42.28M$ 36.22M$ 35.61M
Stockholders Equity$ 755.95M$ 653.08M$ 489.57M$ 522.23M$ 540.77M
Cash Flow-
Free Cash Flow$ 76.99M$ -33.21M$ -31.54M-$ -33.74M
Operating Cash Flow$ -21.23M$ -33.21M$ -26.16M-$ -19.69M
Investing Cash Flow$ 105.19M-$ 3.56M-$ -14.74M
Financing Cash Flow$ 13.39M-$ 1.47M-$ 2.12M
Currency in USD

Krystal Biotech Earnings and Revenue History

Krystal Biotech Debt to Assets

Krystal Biotech Cash Flow

Krystal Biotech Forecast EPS vs Actual EPS

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis